{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:43Z","timestamp":1793379943542,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funding for this project was provided in part by the University of South Alabama College of Medicine Intramural Grants Program."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The success of mRNA vaccines in controlling the COVID 19 pandemic has confirmed the efficacy of synthetically synthesized mRNA in humans and has also provided a blueprint on how to design them in terms of molecular structure and cost. We describe a mRNA vector that, unlike linear mRNAs used in current vaccines\/therapeutics, does not require a 5\u2032 cap to function. The described mRNA vector initiates translation from an internal ribosomal entry site (IRES) and contains specially designed self-folding secondary structures (hairpins) to protect the 5\u2032 end against degradation, dramatically improving its stability. The produced mRNA did not require any additional modifications for functionality. The 5\u2032 hairpins completely inhibited cap-dependent translation, and all vectors containing them required an IRES to express protein. When this capless mRNA vector was constructed to express the full-length Influenza A membrane protein hemagglutinin (HA), complexed with pre-formed lipid-based nanoparticles, and then injected into mice as a vaccine, it generated high titers of anti-HA antibodies and protected mice against a lethal dose of Influenza A.<\/jats:p>","DOI":"10.1038\/s41434-025-00521-0","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T09:42:41Z","timestamp":1740303761000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3137-8650","authenticated-orcid":false,"given":"Victor","family":"Solodushko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-4571","authenticated-orcid":false,"given":"Jin H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Fouty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,23]]},"reference":[{"key":"521_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21:195\u20137.","journal-title":"Nat Rev Immunol"},{"key":"521_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00752-5","volume":"8","author":"CM Kackos","year":"2023","unstructured":"Kackos CM, DeBeauchamp J, Davitt CJH, Lonzaric J, Sealy RE, Hurwitz JL, et al. Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection. NPJ Vaccines. 2023;8:157.","journal-title":"NPJ Vaccines"},{"key":"521_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39376-7","volume":"14","author":"IT Lee","year":"2023","unstructured":"Lee IT, Nachbagauer R, Ensz D, Schwartz H, Carmona L, Schaefers K, et al. Safety and immunogenicity of a phase 1\/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis. Nat Commun. 2023;14:3631.","journal-title":"Nat Commun"},{"key":"521_CR4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMcibr2215281","volume":"388","author":"KM Neuzil","year":"2023","unstructured":"Neuzil KM. An mRNA influenza vaccine\u2014could it deliver? N Engl J Med. 2023;388:1139\u201341.","journal-title":"N Engl J Med"},{"key":"521_CR5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217533119","volume":"119","author":"S Pecetta","year":"2022","unstructured":"Pecetta S, Rappuoli R. mRNA, the beginning of a new influenza vaccine game. Proc Natl Acad Sci USA. 2022;119:e2217533119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"521_CR6","doi-asserted-by":"crossref","unstructured":"Wadhwa A, Aljabbari A, Lokras A, Foged C, Thakur A. Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics. 2020;12:102.","DOI":"10.3390\/pharmaceutics12020102"},{"key":"521_CR7","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"SS Rosa","year":"2021","unstructured":"Rosa SS, Prazeres DMF, Azevedo AM, Marques MPC. mRNA vaccines manufacturing: challenges and bottlenecks. Vaccine. 2021;39:2190\u20132200.","journal-title":"Vaccine"},{"key":"521_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1021\/acs.molpharmaceut.2c00010","volume":"19","author":"C Webb","year":"2022","unstructured":"Webb C, Ip S, Bathula NV, Popova P, Soriano SKV, Ly HH, et al. Current status and future perspectives on MRNA drug manufacturing. Mol Pharm. 2022;19:1047\u201358.","journal-title":"Mol Pharm"},{"key":"521_CR9","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1093\/nar\/gkw551","volume":"44","author":"A Ramanathan","year":"2016","unstructured":"Ramanathan A, Robb GB, Chan SH. mRNA capping: biological functions and applications. Nucleic Acids Res. 2016;44:7511\u201326.","journal-title":"Nucleic Acids Res"},{"key":"521_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/wrna.19","volume":"1","author":"A Ghosh","year":"2010","unstructured":"Ghosh A, Lima CD. Enzymology of RNA cap synthesis. Wiley Interdiscip Rev RNA. 2010;1:152\u201372.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"521_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbagrm.2018.09.011","volume":"1862","author":"A Galloway","year":"2019","unstructured":"Galloway A, Cowling VH. mRNA cap regulation in mammalian cell function and fate. Biochim Biophys Acta Gene Regul Mech. 2019;1862:270\u20139.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"521_CR12","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3762\/bjoc.13.274","volume":"13","author":"F Muttach","year":"2017","unstructured":"Muttach F, Muthmann N, Rentmeister A. Synthetic mRNA capping. Beilstein J Org Chem. 2017;13:2819\u201332.","journal-title":"Beilstein J Org Chem"},{"key":"521_CR13","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1128\/jvi.62.8.2636-2643.1988","volume":"62","author":"SK Jang","year":"1988","unstructured":"Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. A segment of the 5\u2019 nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol. 1988;62:2636\u201343.","journal-title":"J Virol"},{"key":"521_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrm.2017.103","volume":"19","author":"K Leppek","year":"2018","unstructured":"Leppek K, Das R, Barna M. Functional 5\u2019 UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat Rev Mol Cell Biol. 2018;19:158\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"521_CR15","doi-asserted-by":"publisher","first-page":"e1005734","DOI":"10.1371\/journal.pcbi.1005734","volume":"13","author":"AA Gritsenko","year":"2017","unstructured":"Gritsenko AA, Weingarten-Gabbay S, Elias-Kirma S, Nir R, de Ridder D, Segal E. Sequence features of viral and human Internal Ribosome Entry Sites predictive of their activity. PLoS Comput Biol. 2017;13:e1005734.","journal-title":"PLoS Comput Biol"},{"key":"521_CR16","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00018-016-2428-2","volume":"74","author":"R Lacerda","year":"2017","unstructured":"Lacerda R, Menezes J, Romao L. More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer. Cell Mol Life Sci. 2017;74:1659\u201380.","journal-title":"Cell Mol Life Sci"},{"key":"521_CR17","doi-asserted-by":"crossref","unstructured":"Godet AC, David F, Hantelys F, Tatin F, Lacazette E, Garmy-Susini B, et al. IRES trans-acting factors, key actors of the stress response. Int J Mol Sci. 2019;20:924.","DOI":"10.3390\/ijms20040924"},{"key":"521_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fmicb.2012.00092","volume":"3","author":"PJ Hanson","year":"2012","unstructured":"Hanson PJ, Zhang HM, Hemida MG, Ye X, Qiu Y, Yang D. IRES-dependent translational control during virus-induced endoplasmic reticulum stress and apoptosis. Front Microbiol. 2012;3:92.","journal-title":"Front Microbiol"},{"key":"521_CR19","doi-asserted-by":"crossref","unstructured":"Van den Akker GGH, Zacchini F, Housmans BAC, van der Vloet L, Caron MMJ, Montanaro L, et al. Current practice in bicistronic IRES reporter use: a systematic review. Int J Mol Sci. 2021;22:5193.","DOI":"10.3390\/ijms22105193"},{"key":"521_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41434-023-00391-4","volume":"30","author":"V Solodushko","year":"2023","unstructured":"Solodushko V, Fouty B. Terminal hairpins improve protein expression in IRES-initiated mRNA in the absence of a cap and polyadenylated tail. Gene Ther. 2023;30:620\u20137.","journal-title":"Gene Ther"},{"key":"521_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06667-w","volume":"12","author":"JH Kim","year":"2022","unstructured":"Kim JH, Bryant H, Fiedler E, Cao T, Rayner JO. Real-time tracking of bioluminescent influenza A virus infection in mice. Sci Rep. 2022;12:3152.","journal-title":"Sci Rep"},{"key":"521_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/cm.20317","volume":"65","author":"S Lu","year":"2008","unstructured":"Lu S, Borst DE, Horowits R. Expression and alternative splicing of N-RAP during mouse skeletal muscle development. Cell Motil Cytoskeleton. 2008;65:945\u201354.","journal-title":"Cell Motil Cytoskeleton"},{"key":"521_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1261\/rna.069286.118","volume":"25","author":"Z Trepotec","year":"2019","unstructured":"Trepotec Z, Geiger J, Plank C, Aneja MK, Rudolph C. Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life. RNA. 2019;25:507\u201318.","journal-title":"RNA"},{"key":"521_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0079-6603(08)60812-0","volume":"50","author":"S Shuman","year":"1995","unstructured":"Shuman S. Capping enzyme in eukaryotic mRNA synthesis. Prog Nucleic Acid Res Mol Biol. 1995;50:101\u201329.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"521_CR25","doi-asserted-by":"crossref","unstructured":"Wu NC, Wilson IA. Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb Perspect Med. 2020;10:a038778.","DOI":"10.1101\/cshperspect.a038778"},{"key":"521_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.sbi.2021.03.003","volume":"69","author":"BP Phillips","year":"2021","unstructured":"Phillips BP, Miller EA. Membrane protein folding and quality control. Curr Opin Struct Biol. 2021;69:50\u201354.","journal-title":"Curr Opin Struct Biol"},{"key":"521_CR27","doi-asserted-by":"crossref","unstructured":"Avci-Adali M, Behring A, Steinle H, Keller T, Krajeweski S, Schlensak C, et al. In vitro synthesis of modified mRNA for induction of protein expression in human cells. J Vis Exp. 2014;13:e51943.","DOI":"10.3791\/51943-v"},{"key":"521_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/79583","volume":"7","author":"AJ Shatkin","year":"2000","unstructured":"Shatkin AJ, Manley JL. The ends of the affair: capping and polyadenylation. Nat Struct Biol. 2000;7:838\u201342.","journal-title":"Nat Struct Biol"},{"key":"521_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1097-2765(02)00660-3","volume":"10","author":"S Moteki","year":"2002","unstructured":"Moteki S, Price D. Functional coupling of capping and transcription of mRNA. Mol Cell. 2002;10:599\u2013609.","journal-title":"Mol Cell"},{"key":"521_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9192","volume":"6","author":"A Gebhardt","year":"2015","unstructured":"Gebhardt A, Habjan M, Benda C, Meiler A, Haas DA, Hein MY, et al. mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3. Nat Commun. 2015;6:8192.","journal-title":"Nat Commun"},{"key":"521_CR31","doi-asserted-by":"crossref","unstructured":"Duan TL, Jiao H, He GJ, Yan YB. Translation efficiency and degradation of ER-associated mRNAs modulated by ER-anchored poly(A)-specific ribonuclease (PARN). Cells. 2020;9:162.","DOI":"10.3390\/cells9010162"},{"key":"521_CR32","doi-asserted-by":"publisher","first-page":"e1001336","DOI":"10.1371\/journal.pbio.1001336","volume":"10","author":"XA Cui","year":"2012","unstructured":"Cui XA, Zhang H, Palazzo AF. p180 promotes the ribosome-independent localization of a subset of mRNA to the endoplasmic reticulum. PLoS Biol. 2012;10:e1001336.","journal-title":"PLoS Biol"},{"key":"521_CR33","doi-asserted-by":"publisher","first-page":"25907","DOI":"10.1074\/jbc.M114.580688","volume":"289","author":"S Jagannathan","year":"2014","unstructured":"Jagannathan S, Hsu JC, Reid DW, Chen Q, Thompson WJ, Moseley AM, et al. Multifunctional roles for the protein translocation machinery in RNA anchoring to the endoplasmic reticulum. J Biol Chem. 2014;289:25907\u201324.","journal-title":"J Biol Chem"},{"key":"521_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1134\/S0026893321030080","volume":"55","author":"KA Lashkevich","year":"2021","unstructured":"Lashkevich KA, Dmitriev SE. mRNA targeting, transport and local translation in eukaryotic cells: from the classical view to a diversity of new concepts. Mol Biol. 2021;55:507\u201337.","journal-title":"Mol Biol"},{"key":"521_CR35","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","volume":"28","author":"AW Freyn","year":"2020","unstructured":"Freyn AW, Ramos da Silva J, Rosado VC, Bliss CM, Pine M, Mui BL, et al. A multi-targeting, nucleoside-modified mrna influenza virus vaccine provides broad protection in mice. Mol Ther. 2020;28:1569\u201384.","journal-title":"Mol Ther"},{"key":"521_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05482-0","volume":"9","author":"N Pardi","year":"2018","unstructured":"Pardi N, Parkhouse K, Kirkpatrick E, McMahon M, Zost SJ, Mui BL, et al. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies. Nat Commun. 2018;9:3361.","journal-title":"Nat Commun"},{"key":"521_CR37","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1093\/nar\/gkt358","volume":"41","author":"TD Plank","year":"2013","unstructured":"Plank TD, Whitehurst JT, Kieft JS. Cell type specificity and structural determinants of IRES activity from the 5\u2019 leaders of different HIV-1 transcripts. Nucleic Acids Res. 2013;41:6698\u2013714.","journal-title":"Nucleic Acids Res"},{"key":"521_CR38","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/nar\/gkg357","volume":"31","author":"D De Pietri Tonelli","year":"2003","unstructured":"De Pietri Tonelli D, Mihailovich M, Schnurbus R, Pesole G, Grohovaz F, Zacchetti D. Translational control of Scamper expression via a cell-specific internal ribosome entry site. Nucleic Acids Res. 2003;31:2508\u201313.","journal-title":"Nucleic Acids Res"},{"key":"521_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","volume":"348","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang Y, Zhou S, Dain L, Mei L, Zhu G. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Control Release. 2022;348:84\u201394.","journal-title":"J Control Release"},{"key":"521_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2023","unstructured":"Chen R, Wang SK, Belk JA, Amaya L, Li Z, Cardenas A, et al. Engineering circular RNA for enhanced protein production. Nat Biotechnol. 2023;41:262\u201372.","journal-title":"Nat Biotechnol"},{"key":"521_CR41","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1093\/nar\/gkac1252","volume":"51","author":"S Kameda","year":"2023","unstructured":"Kameda S, Ohno H, Saito H. Synthetic circular RNA switches and circuits that control protein expression in mammalian cells. Nucleic Acids Res. 2023;51:e24.","journal-title":"Nucleic Acids Res"},{"key":"521_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9:2629.","journal-title":"Nat Commun"},{"key":"521_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2016.21","volume":"5","author":"AE Grier","year":"2016","unstructured":"Grier AE, Burleigh S, Sahni J, Clough CA, Cardot V, Choe DC, et al. pEVL: a linear plasmid for generating mRNA IVT templates with extended encoded poly(A) sequences. Mol Ther Nucleic Acids. 2016;5:e306.","journal-title":"Mol Ther Nucleic Acids"},{"key":"521_CR44","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1128\/MCB.16.12.6859","volume":"16","author":"TV Pestova","year":"1996","unstructured":"Pestova TV, Hellen CU, Shatsky IN. Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. Mol Cell Biol. 1996;16:6859\u201369.","journal-title":"Mol Cell Biol"},{"key":"521_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.omtn.2021.10.007","volume":"26","author":"S Linares-Fernandez","year":"2021","unstructured":"Linares-Fernandez S, Moreno J, Lambert E, Mercier-Gouy P, Vachez L, Verrier B, et al. Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA. Mol Ther Nucleic Acids. 2021;26:945\u201356.","journal-title":"Mol Ther Nucleic Acids"},{"key":"521_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.718753","volume":"9","author":"T Liu","year":"2021","unstructured":"Liu T, Liang Y, Huang L. Development and delivery systems of mRNA vaccines. Front Bioeng Biotechnol. 2021;9:718753.","journal-title":"Front Bioeng Biotechnol"},{"key":"521_CR47","first-page":"260","volume":"11","author":"V Koppu","year":"2022","unstructured":"Koppu V, Poloju D, Puvvala B, Madineni K, Balaji S, Sheela CMP, et al. Current perspectives and future prospects of mRNA vaccines against viral diseases: a brief review. Int J Mol Cell Med. 2022;11:260\u201372.","journal-title":"Int J Mol Cell Med"},{"key":"521_CR48","doi-asserted-by":"crossref","unstructured":"Li M, Liu M, Song S, Zhao R, Xie Y, Liu J, et al. Influenza a neuraminidase-based bivalent mRNA vaccine induces Th1-type immune response and provides protective effects in mice. Vaccines. 2024;12:300.","DOI":"10.3390\/vaccines12030300"},{"key":"521_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2256422","volume":"12","author":"F Xiong","year":"2023","unstructured":"Xiong F, Zhang C, Shang B, Zheng M, Wang Q, Ding Y, et al. An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses. Emerg Microbes Infect. 2023;12:2256422.","journal-title":"Emerg Microbes Infect"},{"key":"521_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00963-4","volume":"9","author":"X Yue","year":"2024","unstructured":"Yue X, Zhong C, Cao R, Liu S, Qin Z, Liu L, et al. CircRNA based multivalent neuraminidase vaccine induces broad protection against influenza viruses in mice. NPJ Vaccines. 2024;9:170.","journal-title":"NPJ Vaccines"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00521-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:23:37Z","timestamp":1757143417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00521-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00521-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,23]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VS and BF are named on a patent application by the University of South Alabama that describes the use of 5\u2019 terminal hairpins to generate capless synthetic mRNA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal work was approved by the IACUC Committee of the University of South Alabama (Animal protocol number 2135741).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}